Joshua Pacheco - Concepedia

Concepedia

Author

Joshua Pacheco

Amsterdam UMC Location University of Amsterdam

Also Known As

J. Pacheco, Joshua J. Pacheco, Joshua Pacheco

21

Publications

1.2K

Citations

11

H-Index

33

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam Framingham State University University of Michigan California Institute of Technology

JP

About

Joshua Pacheco is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	247
2	Biochemistry	2	2	133
3	Natural Sciences	1	1	72
4	Social Sciences	1	1	35
5	Biomolecular Engineering	1	1	72

Joshua Pacheco

×

12

Publications

1.2K

Citations

11

H-Index

	Year	Citations
Synthesis of terephthalic acid via Diels-Alder reactions with ethylene and oxidized variants of 5-hydroxymethylfurfural Joshua Pacheco, Mark E. Davis Proceedings of the National Academy of Sciences	2014	282
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease Yumiko Taguchi, Jun Liu, Jiapeng Ruan, Journal of Neuroscience	2017	235
Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis James C. Dodge, Christopher M. Treleaven, Joshua Pacheco, Proceedings of the National Academy of Sciences	2015	130
Route to Renewable PET: Reaction Pathways and Energetics of Diels–Alder and Dehydrative Aromatization Reactions Between Ethylene and Biomass-Derived Furans Catalyzed by Lewis Acid Molecular Sieves Joshua Pacheco, Jay A. Labinger, Alex L. Sessions, ACS Catalysis	2015	104
Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice # Hongmei Zhao, Malgorzata Przybylska, I-Huan Wu, Hepatology	2009	89
Lyso-sphingomyelin is elevated in dried blood spots of Niemann–Pick B patients Wei‐Lien Chuang, Joshua Pacheco, Samantha Cooper, Molecular Genetics and Metabolism Dried Blood SpotsHematologyPathologyDermatologyScleroderma	2013	79
Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease John Marshall, Karen M. Ashe, Dinesh S. Bangari, PLoS ONE Enzyme TherapyGlycobiologySubstrate Reduction TherapyCarbohydrate-protein InteractionSubstrate Reduction	2010	72
Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann–Pick C mice Jennifer B. Nietupski, Joshua Pacheco, Wei‐Lien Chuang, Molecular Genetics and Metabolism Molecular PharmacologyBiochemistryMedicineExperimental TherapeuticNeuropharmacology	2012	61
Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics James Murray, Anne Marie Thompson, Allison Vitsky, Molecular Genetics and Metabolism	2014	52
Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease Mario A. Cabrera-Salazar, Scott D. Bercury, Robin J. Ziegler, Experimental Neurology Neurodegenerative DiseasesNeuroregenerationAlzheimer's DiseasePhysiologyNeuroprotection	2010	35

Page 1